<DOC>
	<DOCNO>NCT02498080</DOCNO>
	<brief_summary>Percutaneous transluminal angioplasty ( PTA ) infra-popliteal artery patient suffer peripheral arterial occlusive disease ( PAOD ) provide good result term limb salvage . During last decade , drug elute balloon ( DEB ) find effective tool treatment atherosclerotic disease several arterial district . Aim study compare result DEB PTA versus standard PTA infra-popliteal district patient CLI , single-centre prospective randomize trial .</brief_summary>
	<brief_title>Drug Eluting Balloons PTA Infra-popliteal Arteries Patients With Critical Limb Ischemia</brief_title>
	<detailed_description>Percutaneous transluminal angioplasty ( PTA ) infra-popliteal artery patient suffer peripheral arterial occlusive disease ( PAOD ) provide good result term limb salvage . Nevertheless , treatment still burden consistent restenosis reintervention rate 68 % 50 % , respectively . During last decade , drug elute balloon ( DEB ) find effective tool treatment atherosclerotic disease several arterial district . DEBs coat antimitotic drug ( usually paclitaxel ) order inhibit endothelial cell proliferation . Paclitaxel effectiveness due drug lipophilicity . A short ( 1 3 minute ) balloon inflation target vessel level sufficient deliver therapeutic dose paclitaxel , last situ thereafter month . The effectiveness DEBs already proven coronary well femoro-popliteal district : DEBs improve primary patency rate de novo lesion femoro-popliteal intrastent restenosis . A role DEBs treatment infra-popliteal lesion district patient critical limb ischemia ( CLI ) also describe , however result specific anatomical site still controversial . The DEBATE-BTK Trial show DEBs reduce 1-year restenosis , target lesion revascularization ( TLR ) target vessel occlusion rate treatment infra-popliteal lesion diabetic patient CLI , compare standard PTA . On hand , IN.PACT DEEP Trial show high major amputation rate lower amputation-free survival DEB compare standard PTA . It hypothesize DEBs failure could relate different material drug coat process old DEBs , result insufficient dose deliver target vessel wall . Aim study compare result DEB PTA versus standard PTA infra-popliteal district patient CLI , single-centre prospective randomize trial . Patients Methods Study Design : single-centre , parallel-arms , PROBE ( Prospective Randomized Open Blinded End-Point ) trial . The study submit Ethical Committee IRCCS NEUROMED perform accord Helsinki Declaration . All patient sign inform consent inclusion study . Inclusion criterion : patient CLI ( Rutherford class 4 , 5 , 6 ) , stenosis and/or complete occlusion P3 popliteal artery segment , stenosis and/or complete occlusion least 1 leg vessel &gt; 40 mm length , life-expectancy &gt; 12 month , possibility perform angiogram 12-months follow-up . Exclusion criterion : life-expectancy &lt; 12 month , iodinate contrast medium paclitaxel allergy , impossibility undergo dual antiplatelet therapy . Randomization : Lesions randomly assign DEB PTA standard PTA successful passage guidewire . Randomization perform block 10 use computer-generated random digit , assignment place sealed envelope . Intraoperative detail : PTA procedures usually perform antegrade approach 5 Fr sheath , systemic anticoagulation ( Heparin Sodium 70 IU/kg ) . In patient randomised DEB PTA , predilatation standard balloon always perform . When 1 DEB need , 5 mm overlap zone balloon always consider . In case , regardless type balloon , inflation length 3 minute . At completion angiogram , case flow-limiting dissection &gt; 30 % residual stenosis , 3 minute PTA perform . Coronary stent use bailout . Technical success define successful recanalization target vessel direct flow foot , residual stenosis &lt; 30 % . Inflow lesion above-the-knee ( ATK ) segment treat session . Patients bilateral lesion treat different procedure . After intervention , patient usually treat dual antiplatelet therapy ( acetylsalicylic acid 100 mg/day Clopidogrel 75 mg/day ) least 4 week , follow lifelong single antiplatelet therapy ( acetylsalicylic acid 100 mg/day ) . All DEB PTAs perform Ranger Balloon ( Boston Scientific , Natick , MA , USA ) . This balloon provide Sterling platform associate load tool aim protect balloon surface insertion inside sheath , order avoid drug loss intra-arterial navigation . Paclitaxel coat balloon surface citrate ester peculiar form , allow provide optimal drug dose release target vessel wall . Follow-up : Duplex Ultrasound Scans ( DUS ) schedule 1 , 3 6 month intervention . At 1 year follow-up , patient undergo digital subtraction angiography ( DSA ) . The latter DSA compare intraoperative diagnostic imaging use projection . Trophic lesion care perform weekly visit first 2 month , follow bimonthly visit next 2 month . Visits schedule monthly ulcer heal . Planned minor amputation non-infected patient perform within 1 month index procedure . Primary outcome : 12-months binary restenosis rate , define lumen loss &gt; 50 % DSA . Secondary outcome : clinically drive target lesion revascularization ( CD-TLR ) rate , major amputation rate , wound heal rate , 12-months target vessel occlusion rate DSA . Acquired angiogram DUS scan review 2 blinded investigator actively participate recruitment knowledge randomization group . Study power : Assuming binary restenosis rate conventional PTA 75 % reduction least 50 % DEB 4 , minimum 41 lesion group evaluate statistical power 90 % significance level alpha=0.05 ( two-sided ) . Assuming occlusion rate target lesion conventional PTA 55 % reduction least 60 % DEB 4 , minimum 44 lesion group evaluate statistical power 90 % significance level alpha=0.05 ( two-sided ) . The number lesion could increase 50 randomization group maximise power study . Assuming rate eligible lesion per patient 1.3 , minimum 78 patient enrol study . Statistical analysis . Continuous variable express means±standard deviation median interquartile range percentage categorical variable . Variables positive skewness analyse logarithmic transformation . To compare characteristic two randomization group , Student 's test use continuous variable X2 test categorical variable ( Exact Fisher 's test use cell frequency &lt; 6 ) . Concordance data ecodoppler angiography test Bland-Altman method . The `` intention treat '' principle adopt analysis primary endpoint : evaluation efficacy take account initial randomization independently compliance treatment subject . The rate primary outcomes two randomization group compare Kaplan-Meier method , follow long-rank test , e multivariate logistic analysis , adjust possible confounding . The data analysis generate use SAS/STAT software , Version 9.1.3 SAS System Windows©2009 . SAS Institute Inc. SAS register trademark SAS Institute Inc. , Cary , NC , USA . Timeline : Taking account recruitment capacity centre 60 eligible patient per year , recruitment phase last 15 month total duration study 36 month . Month 0-3 : protocol preparation , ethical committee approval , patient identification Month 4-19 : enrolment patient Month 12 : ad interim analysis result . Required high rate success DEB report study . Month 16-31 : follow-up . Month 32-36 : Data analysis publication result</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>patient CLI ( Rutherford class 4 , 5 , 6 ) ; stenosis and/or complete occlusion P3 popliteal artery segment ; stenosis and/or complete occlusion least 1 leg vessel &gt; 40 mm length ; lifeexpectancy &gt; 12 month ; possibility perform angiogram 12months followup . lifeexpectancy &lt; 12 month ; iodinate contrast medium paclitaxel allergy ; impossibility undergo dual antiplatelet therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Drug elute balloon</keyword>
	<keyword>Critical limb ischemia</keyword>
	<keyword>Infra-popliteal artery</keyword>
	<keyword>Percutaneous transluminal angioplasty</keyword>
</DOC>